Mraz Amerine & Associates Inc. Sells 13,251 Shares of Ambev S.A. (NYSE:ABEV)

Mraz Amerine & Associates Inc. lowered its holdings in Ambev S.A. (NYSE:ABEV) by 1.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 834,723 shares of the company’s stock after selling 13,251 shares during the quarter. Mraz Amerine & Associates Inc.’s holdings in Ambev were worth $2,337,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in ABEV. Perennial Advisors LLC bought a new stake in Ambev during the third quarter worth about $26,000. Coldstream Capital Management Inc. bought a new stake in shares of Ambev during the third quarter valued at approximately $26,000. Integrated Wealth Concepts LLC bought a new stake in shares of Ambev during the third quarter valued at approximately $26,000. Ieq Capital LLC bought a new stake in shares of Ambev during the third quarter valued at approximately $27,000. Finally, Brown Brothers Harriman & Co. grew its stake in shares of Ambev by 117.5% during the first quarter. Brown Brothers Harriman & Co. now owns 8,233 shares of the company’s stock valued at $27,000 after purchasing an additional 4,448 shares during the last quarter. Institutional investors own 8.13% of the company’s stock.

Ambev Price Performance

ABEV remained flat at $2.26 during mid-day trading on Wednesday. 15,315,613 shares of the company’s stock traded hands, compared to its average volume of 11,981,535. The business’s fifty day simple moving average is $2.50 and its two-hundred day simple moving average is $2.63. The company has a debt-to-equity ratio of 0.03, a current ratio of 0.89 and a quick ratio of 0.66. The firm has a market cap of $35.52 billion, a price-to-earnings ratio of 12.58, a price-to-earnings-growth ratio of 2.35 and a beta of 1.08. Ambev S.A. has a 12 month low of $2.24 and a 12 month high of $3.23.

Ambev (NYSE:ABEV) last issued its quarterly earnings data on Thursday, February 29th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.01. Ambev had a net margin of 18.19% and a return on equity of 17.60%. The company had revenue of $4.04 billion during the quarter. As a group, research analysts expect that Ambev S.A. will post 0.19 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently commented on ABEV shares. JPMorgan Chase & Co. reissued a “neutral” rating on shares of Ambev in a research note on Friday, March 1st. Barclays lowered shares of Ambev from an “overweight” rating to an “equal weight” rating and cut their price objective for the company from $3.50 to $3.00 in a report on Monday, March 4th. Finally, StockNews.com began coverage on shares of Ambev in a report on Friday, January 26th. They issued a “buy” rating on the stock. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, Ambev has a consensus rating of “Moderate Buy” and an average target price of $3.20.

About Ambev

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, other non-alcoholic beverages, malt, and food products. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe and Hoegaarden, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.